- Home
- IMUX vs BMR Comparison
IMUX vs BMR Comparison
Compare IMUX & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- BMR
- Stock Information
- Founded
- IMUX 2016
- BMR 2009
- Country
- IMUX United States
- BMR Israel
- Employees
- IMUX N/A
- BMR N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- BMR Computer Software: Prepackaged Software
- Sector
- IMUX Health Care
- BMR Technology
- Exchange
- IMUX Nasdaq
- BMR Nasdaq
- Market Cap
- IMUX 67.1M
- BMR 59.3M
- IPO Year
- IMUX N/A
- BMR 2023
- Fundamental
- Price
- IMUX $0.72
- BMR $3.19
- Analyst Decision
- IMUX Strong Buy
- BMR
- Analyst Count
- IMUX 6
- BMR 0
- Target Price
- IMUX $11.60
- BMR N/A
- AVG Volume (30 Days)
- IMUX 2.4M
- BMR 1.0M
- Earning Date
- IMUX 08-07-2025
- BMR 08-05-2025
- Dividend Yield
- IMUX N/A
- BMR N/A
- EPS Growth
- IMUX N/A
- BMR N/A
- EPS
- IMUX N/A
- BMR N/A
- Revenue
- IMUX N/A
- BMR $3,064,000.00
- Revenue This Year
- IMUX N/A
- BMR $21.21
- Revenue Next Year
- IMUX N/A
- BMR N/A
- P/E Ratio
- IMUX N/A
- BMR N/A
- Revenue Growth
- IMUX N/A
- BMR 5.33
- 52 Week Low
- IMUX $0.56
- BMR $1.86
- 52 Week High
- IMUX $2.11
- BMR $6.59
- Technical
- Relative Strength Index (RSI)
- IMUX 36.47
- BMR 51.92
- Support Level
- IMUX $0.71
- BMR $2.88
- Resistance Level
- IMUX $0.91
- BMR $4.32
- Average True Range (ATR)
- IMUX 0.07
- BMR 0.31
- MACD
- IMUX 0.00
- BMR -0.04
- Stochastic Oscillator
- IMUX 29.20
- BMR 20.19
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.